Mortality in HIV infected individuals in Pune, India

Indian Journal of Medical Research

Volumn 133, Issue 4, 2011, Pages 414-420

  Ghate, Manisha ^a   Deshpande, Swapna ^a   Tripathy, Srikanth ^a   Godbole, Sheela ^a   Nene, Madhura ^a   Thakar, Madhuri ^a   Risbud, Arun ^a   Bollinger, Robert ^b   Mehendale, Sanjay ^c  

^a NATIONAL AIDS RESEARCH INSTITUTE   (India)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c National Institute of Epidemiology   (India)

Author keywords

ART; CD4 count; HIV; Immunosuppression; India; Mortality

Indexed keywords

ANTIRETROVIRUS AGENT; SULFAMETHOXAZOLE; TRIMETHOPRIM;

ACUTE GASTROENTERITIS; ADULT; ARTICLE; CAUSE OF DEATH; CD4 LYMPHOCYTE COUNT; CLINICAL TRIAL; CRYPTOCOCCAL MENINGITIS; DEATH CERTIFICATE; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; HEART INFARCTION; HEPATORENAL SYNDROME; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; INDIA; LACTIC ACIDOSIS; LEUKOENCEPHALOPATHY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS JIROVECII PNEUMONIA; PNEUMOCYSTIS PNEUMONIA; SEPTICEMIA; TOXOPLASMOSIS; TUBERCULOSIS; VIRUS LOAD;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; COMORBIDITY; EARLY DIAGNOSIS; HIV INFECTIONS; HUMANS; IMMUNOSUPPRESSION; INDIA; PROSPECTIVE STUDIES; TUBERCULOSIS;

EID: 79955720344     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Pandey A, Reddy DC, Ghys PD, Thomas M, Sahu D, Bhattacharya M, et al. Improved estimates of India's HIV burden in 2006. Indian J Med Res 2009; 129: 50-8.
2. Indexmundi.com. Available from: http://www.indexmundi.com/india, accessed on November 13, 2009.
3. Yang C, Huang Y, Hsiao C, Yeh Y-L, Liou H-R, Hung C-C, et al. Trends of mortality and causes of death among HIV-infected patients in Taiwan, 1984-2005. HIV Med 2008; 9: 535-43.
4. Zhang F, Dou Z, Yu L, Xu J, Jiao JH, Wanget N, et al. The effect of highly active antiretroviral therapy on mortality among HIV-infected former plasma donors in China. Clin Infect Dis 2008; 47: 825-33.
5. Kumarasamy N, Solomon S, Chaguturu SK, Cecelia AJ, Vallabhaneni S, Flanigan TP, et al. The changing natural history of HIV disease: before and after the introduction of generic antiretroviral therapy in southern India. Clin Infect Dis 2005; 41: 1525-8.
6. Teja VD, Sudha T, Lakshmi V. Causes and pattern of mortality in HIV-infected, hospitalized patients in a tertiary care hospital: a fourteen year study. Indian J Med Sci 2007; 61: 555-61.
7. Sharma SK, Kadhiravan T, Banga A, Goyal T, Bhatia I, Saha PK. Spectrum of clinical disease in a series of 135 hospitalised HIV-infected patients from north India. BMC Infect Dis 2004; 4: 52.
8. Sobhani R, Basavaraj A, Gupta A, Bhave AS, Kadam DB, Sangle SA, et al. Mortality & clinical characteristics of hospitalized adult patients with HIV in Pune, India. Indian J Med Res 2007; 126: 116-21.
9. Kumarasamy N, Solomon S, Flanigan TP, Hemalatha R, Thyagarajan SP, Mayer KH. Natural history of human immunodefciency virus disease in southern India. Clin Infect Dis 2003; 36: 79-85.
10. Hira SK, Shroff HJ, Lanjewar DN, Dholkia YN, Bhatia VP, Dupont HL.The natural history of human immunodefciency virus infection among adults in Mumbai. Natl Med J India 2003; 16: 126-31.
11. Hira SK, Srinivasa Rao AS, Thanekar J. Evidence of AIDS related mortality in Mumbai, India. Lancet 1999; 354:1175-6.
12. Ghate M, Deshpande S, Tripathy S, Nene M, Gedam P, Godbole S, et al. Incidence of common opportunistic infections in HIV-infected individuals in Pune, India: analysis by stages of immunosuppression represented by CD4 counts. Int J Infect Dis 2009; 13: e1-8.
13. NACO (2007) National AIDS Control Organization, Ministry of Health and Family Welfare, Government of India, New Delhi. Available from: http://www.nacoonline.org/guidelines/ART_Guidelines.pdf, accessed on August 31, 2007.
14. Casseb J, Fonseca LA, Veiga AP, de Almeida A, Bueno A, Ferez AC, et al. AIDS incidence and mortality in a hospital-based cohort of HIV-1-seropositive patients receiving highly active antiretroviral therapy in São Paulo, Brazil. AIDS Patient Care STDS 2003; 17: 447-52.
15. Losina E, Figueroa P, Duncan J, Divi N, Wolf LL, Hirschhorn LR, et al. HIV morbidity and mortality in Jamaica: analysis of national surveillance data, 1993-2005. Int J Infect Dis 2008; 12:132-8.
16. Lawn SD, Harries AD, Anglaret X, Myer L, Wood R. Early mortality among adults accessing antiretroviral treatment programmes in Sub-Saharan Africa. AIDS 2008; 22:1897-908.
17. The HIV-CAUSAL Collaboration. The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals. AIDS 2010; 24: 123-37.
18. th April 2009, T-11020/36/2005-NACO (ART). New Delhi: Government of India, Department of AIDS Control, National AIDS Control Organization; 2009.
19. Pacheco AG, Durovni B, Cavalcante SC, Lauria LM, Moore RD, Moulton LH, et al. AIDS-Related Tuberculosis in Rio de Janeiro, Brazil. PLoS One 2008; 3:e3132.
20. Schiffer JT, Sterling TR. Timing of antiretroviral therapy initiation in tuberculosis patients with AIDS: a decision analysis. J Acquir Immune Defc Syndr 2007; 44: 229-34.
21. National AIDS Control Organization (NACO). Operational guidelines for community care centres. New Delhi: Ministry of Health and Family Welfare, NACO 2007. Available from: http://www.nacoonline.org/upload/Publication/Treatment%20Care%20and%20support/Guidelines%20for%20Community%20Care%20Centre%20-.pdf, accessed on September 9, 2010.